Axon Enterprise, Inc (NASDAQ:AXON) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Axon Enterprise, Inc (NASDAQ:AXON) have been assigned a consensus rating of “Moderate Buy” from the nineteen brokerages that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, sixteen have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $712.75.

A number of brokerages have recently commented on AXON. Craig Hallum reissued a “buy” rating and set a $820.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 25th. Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 8th. TD Cowen lowered their price objective on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating for the company in a research report on Wednesday, April 8th. Zacks Research raised Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 19th. Finally, Citizens Jmp lowered their price objective on Axon Enterprise from $825.00 to $700.00 and set a “market outperform” rating for the company in a research report on Thursday, May 7th.

Insider Transactions at Axon Enterprise

In related news, insider Isaiah Fields sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $400.00, for a total value of $800,000.00. Following the completion of the transaction, the insider directly owned 52,813 shares of the company’s stock, valued at $21,125,200. This represents a 3.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CRO Cameron Brooks sold 1,242 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $621,000.00. Following the completion of the transaction, the executive directly owned 49,710 shares of the company’s stock, valued at $24,855,000. This trade represents a 2.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 39,344 shares of company stock valued at $19,267,315 over the last three months. 4.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Axon Enterprise

Several hedge funds and other institutional investors have recently bought and sold shares of AXON. Baillie Gifford & Co. raised its stake in Axon Enterprise by 1,198.7% during the 4th quarter. Baillie Gifford & Co. now owns 1,642,578 shares of the biotechnology company’s stock worth $932,869,000 after acquiring an additional 1,516,099 shares in the last quarter. Edgewood Management LLC acquired a new stake in Axon Enterprise during the 4th quarter worth $846,516,000. Wellington Management Group LLP raised its stake in Axon Enterprise by 326.9% during the 4th quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company’s stock worth $874,463,000 after acquiring an additional 1,179,038 shares in the last quarter. Norges Bank acquired a new stake in Axon Enterprise during the 4th quarter worth $515,764,000. Finally, Vanguard Group Inc. raised its stake in Axon Enterprise by 4.2% during the 3rd quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock worth $6,684,217,000 after acquiring an additional 376,904 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $471.06 on Tuesday. The company has a market cap of $37.97 billion, a P/E ratio of 189.18, a P/E/G ratio of 8.84 and a beta of 1.45. The stock has a 50-day moving average of $408.45 and a two-hundred day moving average of $491.12. Axon Enterprise has a 1-year low of $339.01 and a 1-year high of $885.91. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. The firm had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.91 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.Axon Enterprise’s revenue was up 33.7% compared to the same quarter last year. During the same period last year, the business posted $1.47 earnings per share. As a group, analysts anticipate that Axon Enterprise will post 1.82 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.